BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3154706)

  • 21. Relation between pharmacodynamic and anthropometric parameters during ergometry at rest and after repeated intake of metoprolol in healthy volunteers: results of a pilot study.
    Koch HJ; Raschka C
    Acta Physiol Hung; 2004; 91(1):67-72. PubMed ID: 15334832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that calcium channel blockade prevents cyclosporine-induced exacerbation of renal ischemic injury.
    Bia MJ; Tyler K
    Transplantation; 1991 Feb; 51(2):293-5. PubMed ID: 1847248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of verapamil and nitrendipine on the left ventricular mass and function (systolic and diastolic) in arterial hypertension].
    González-Juanatey JR; García-Acuña JM; Calvo Gómez C; Amaro Cendón A; Fernández-López JA; Gil de la Peña M
    Rev Esp Cardiol; 1994 Jun; 47(6):375-83. PubMed ID: 8066309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine.
    Hofmann J; Wolf A; Spitaler M; Böck G; Drach J; Ludescher C; Grunicke H
    J Cancer Res Clin Oncol; 1992; 118(5):361-6. PubMed ID: 1349891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the Arg389Gly β₁-adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype-dependent response to metoprolol treatment.
    Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Hjelvang BR; Henriksen T; Frandsen E; Forman JL; Torp-Pedersen C; Køber L; Poulsen HE
    Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):779-85. PubMed ID: 22703382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects on left ventricular performance of verapamil and metoprolol singly and together in exercise-induced angina pectoris.
    Silke B; Verma SP; Nelson GI; Hussain M; Forsyth D; Frais MA; Taylor SH
    Am Heart J; 1985 Jun; 109(6):1286-93. PubMed ID: 3890505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with verapamil and nitrendipine in patients with hypertension.
    Nalbantgil I; Onder R; Kiliçcioğlu B; Türkoğlu C
    J Hum Hypertens; 1993 Jun; 7(3):305-8. PubMed ID: 8345499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance and cardiovascular effects of single dose felodipine/beta-blocker combinations in healthy subjects.
    Carruthers SG; Bailey DG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S169-76. PubMed ID: 2442512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do beta blockers differ in their effects on hepatic microsomal enzymes and liver blood flow?
    Parker G; Ene MD; Daneshmend TK; Roberts CJ
    J Clin Pharmacol; 1984; 24(11-12):493-9. PubMed ID: 6150945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of hemodynamics in tachycardiac atrial fibrillation by metoprolol and verapamil].
    Maier WD; Neuss H; Bilgin Y; Gigler G; Thormann J; Schlepper M
    Z Kardiol; 1983 Aug; 72(8):465-70. PubMed ID: 6624186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
    Kindermann M; Maack C; Schaller S; Finkler N; Schmidt KI; Läer S; Wuttke H; Schäfers HJ; Böhm M
    Circulation; 2004 Jun; 109(25):3182-90. PubMed ID: 15184276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute haemodynamic effects of felodipine and verapamil in man, singly and with metoprolol.
    Rönn O; Bengtsson B; Edgar B; Raner S
    Drugs; 1985; 29 Suppl 2():16-25. PubMed ID: 3987543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels and beta-blocking effect of alpha-hydroxymetoprolol--metabolite of metoprolol--in the dog.
    Regårdh CG; Ek L; Hoffmann KJ
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):471-9. PubMed ID: 43384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations.
    Abrahamsson B; Lücker P; Olofsson B; Regårdh CG; Sandberg A; Wieselgren I; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S46-54. PubMed ID: 1968913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide.
    Bril A; Forest MC; Cheval B; Faivre JF
    Cardiovasc Res; 1998 Jan; 37(1):130-40. PubMed ID: 9539867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.